These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2808796)

  • 1. Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy.
    Richard M; Truchetet F; Friedel J; Leclech C; Heid E
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):797-9. PubMed ID: 2808796
    [No Abstract]   [Full Text] [Related]  

  • 2. Gottron's papules-like eruption developing under hydroxyurea therapy.
    Slobodin G; Lurie M; Munichor M; Kovalev J; Rosner I
    Rheumatol Int; 2006 Jun; 26(8):768-70. PubMed ID: 16583187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea.
    Neill B; Ryser T; Neill J; Aires D; Rajpara A
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatomyositis-like skin changes with long-term hydroxyurea (Litalir) therapy].
    Weber L; Schick E; Merkel M; Pillekamp H; Sterry W
    Hautarzt; 1995 Oct; 46(10):717-21. PubMed ID: 7499134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
    Nofal A; El-Din ES
    Int J Dermatol; 2012 May; 51(5):535-41. PubMed ID: 22515579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple keratosis induced by hydroxyurea].
    Grange F; Couilliet D; Audhuy B; Krzisch S; Schlecht P; Guillaume JC
    Ann Dermatol Venereol; 1995; 122(1-2):16-8. PubMed ID: 7668775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
    Ito E; Muro Y; Shibata A; Sugiura K; Akiyama M
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea-induced dermatomyositis koebnerizing at the site of previous shingles.
    Veraitch O; Curto-Garcia N; Harrison C; Stefanato CM; McGibbon D
    Clin Exp Dermatol; 2019 Jul; 44(5):546-548. PubMed ID: 30411394
    [No Abstract]   [Full Text] [Related]  

  • 9. Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?
    de Unamuno-Bustos B; Ballester-Sánchez R; Sabater Marco V; Vilata-Corell JJ
    Actas Dermosifiliogr; 2014 Nov; 105(9):876-8. PubMed ID: 24666578
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatomyositis-like eruption induced by hydroxyurea: a case report.
    Janerowicz D; Czarnecka-Operacz M; Stawny M; Silny W
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):131-4. PubMed ID: 19784527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-dermatomyositis as a complication of hydroxyurea therapy.
    Marie I; Joly P; Levesque H; Heron F; Courville P; Cailleux N; Courtois H
    Clin Exp Rheumatol; 2000; 18(4):536-7. PubMed ID: 10949738
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
    Salmon-Ehr V; Grosieux C; Potron G; Kalis B
    Dermatology; 1998; 196(2):274. PubMed ID: 9568428
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure.
    Kalajian AH; Cely SJ; Malone JC; Burruss JB; Callen JP
    Arch Dermatol; 2010 Mar; 146(3):305-10. PubMed ID: 20231502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis-like eruption following hydroxyurea therapy.
    Rocamora V; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):227-8. PubMed ID: 11032076
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea].
    Martorell-Calatayud A; Requena C; Nagore-Enguídanos E; Guillén-Barona C
    Actas Dermosifiliogr; 2009 Nov; 100(9):804-7. PubMed ID: 19889302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral keratoses and leucocytoclastic vasculitis occurring during treatment of essential thrombocythaemia with hydroxyurea.
    Worley B; Glassman SJ
    Clin Exp Dermatol; 2016 Mar; 41(2):166-9. PubMed ID: 26269121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea-associated squamous dysplasia.
    Sanchez-Palacios C; Guitart J
    J Am Acad Dermatol; 2004 Aug; 51(2):293-300. PubMed ID: 15280852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea-induced dermatomyositis-like eruption.
    Senet P; Aractingi S; Porneuf M; Perrin P; Duterque M
    Br J Dermatol; 1995 Sep; 133(3):455-9. PubMed ID: 8547004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous lesions induced by long-term use of hydroxyurea].
    Sigal M; Crickx B; Blanchet P; Perron J; Simony J; Belaïch S
    Ann Dermatol Venereol; 1984; 111(10):895-900. PubMed ID: 6240956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.